Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia

Cancer Research

Volumn 75, Issue 11, 2015, Pages 2222-2231

  Kim, Jin A ^a   Shim, Jae Seung ^a   Lee, Ga Young ^a   Yim, Hyeon Woo ^a   Kim, Tae Min ^a   Kim, Myungshin ^a   Leem, Sun Hee ^b   Lee, Jong Wook ^c   Min, Chang Ki ^c   Oh, Il Hoan ^a  

^a The Catholic University of Korea   (South Korea)

^b Dong A University   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

JAGGED1; STROMAL CELL DERIVED FACTOR 1; CALCIUM BINDING PROTEIN; CXCL12 PROTEIN, HUMAN; MEMBRANE PROTEIN; SERRATE PROTEINS; SIGNAL PEPTIDE;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PROGNOSIS; CANCER STEM CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; EX VIVO STUDY; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKEMOGENESIS; MESENCHYMAL STROMA CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL NICHE; TUMOR MICROENVIRONMENT; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; CELL LINEAGE; CELL PROLIFERATION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIETIC STEM CELL; METABOLISM; PATHOLOGY; PROGNOSIS;

ANIMALS; BONE MARROW CELLS; CALCIUM-BINDING PROTEINS; CELL LINEAGE; CELL PROLIFERATION; CHEMOKINE CXCL12; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPOIETIC STEM CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOID, ACUTE; MEMBRANE PROTEINS; MESENCHYMAL STROMAL CELLS; MICE; PROGNOSIS; STEM CELL NICHE; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84932620908     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-3379     Document Type: Article

References (49)

1. Estey E, Dohner H. Acute myeloid leukaemia. Lancet 2006;368: 1894-907.
2. Hope KJ, Jin L, Dick JE. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004;5: 738-43.
3. Passegue E, Jamieson CH, Ailles LE, Weissman IL. Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci U S A 2003;100 Suppl 1: 11842-9.
4. Lane SW, Scadden DT, Gilliland DG. The leukemic stem cell niche: Current concepts and therapeutic opportunities. Blood 2009;114: 1150-7.
5. Oh IH, Kwon KR. Concise review: Multiple niches for hematopoietic stem cell regulations. Stem Cells 2010;28: 1243-9.
6. Hooper AT, Butler JM, Nolan DJ, Kranz A, Iida K, Kobayashi M, et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 2009;4: 263-74.
7. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS.Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008;452: 442-7.
8. + cells through Wnt signaling. Nat Immunol 2007;8: 1123-31.
9. Chan CK, Chen CC, Luppen CA, Kim JB, DeBoer AT, Wei K, et al. Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature 2009;457: 490-4.
10. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007;131: 324-36.
11. Chitteti BR, Cheng YH, Streicher DA, Rodriguez-Rodriguez S, Carlesso N, Srour EF, et al. Osteoblast lineage cells expressing high levels of Runx2 enhance hematopoietic progenitor cell proliferation and function. J Cell Biochem 2010;111: 284-94.
12. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010;466: 829-34.
13. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012;481: 457-62.
14. Greenbaum A, Hsu YM, Day RB, Schuettpelz LG, Christopher MJ, Borgerding JN, et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 2013;495: 227-30.
15. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425: 841-6.
16. Kim JA, Kang YJ, Park G, Kim M, Park YO, Kim H, et al. Identification of a stroma-mediated Wnt/beta-catenin signal promoting self-renewal of hematopoietic stem cells in the stem cell niche. Stem Cells 2009;27: 1318-29.
17. Omatsu Y, Sugiyama T, Kohara H, Kondoh G, Fujii N, Kohno K, et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 2010;33: 387-99.
18. Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006;25: 977-88.
19. Nakamura Y, Yahata T, Muguruma Y, Uno T, Sato T, Matsuzawa H, et al. Angiopoietin-1 supports induction of hematopoietic activity in human CD34-bone marrow cells. Exp Hematol 2007;35: 1872-83.
20. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003;425: 836-41.
21. Stier S, Ko Y, Forkert R, Lutz C, Neuhaus T, Grunewald E, et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 2005;201: 1781-91.
22. Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005; 106: 1232-9.
23. Arai F, Suda T. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann N Y Acad Sci 2007;1106: 41-53.
24. Mayack SR, Wagers AJ.Osteolineage niche cells initiate hematopoietic stem cell mobilization. Blood 2008;112: 519-31.
25. Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol 2007;25: 1315-21.
26. Colmone A, Amorim M, Pontier AL, Wang S, Jablonski E, Sipkins DA. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 2008;322: 1861-5.
27. Zhang B, Ho YW, Huang Q, Maeda T, Lin A, Lee SU, et al. Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer Cell 2012;21: 577-92.
28. Frisch BJ, Ashton JM, Xing L, Becker MW, Jordan CT, Calvi LM. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood 2012;119: 540-50.
29. Schepers K, Pietras EM, Reynaud D, Flach J, Binnewies M, Garg T, et al. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 2013;13: 285-99.
30. Carlesso N, Cardoso AA. Stem cell regulatory niches and their role in normal and malignant hematopoiesis. Curr Opin Hematol 2010;17: 281-6.
31. Tabe Y, Konopleva M. Advances in understanding the leukaemia microenvironment. Br J Haematol 2014;164: 767-78.
32. Jung J, Moon N, Ahn JY, OhEJ, Kim M, Cho CS, et al. Mesenchymal stromal cells expanded in human allogenic cord blood serum display higher selfrenewal and enhanced osteogenic potential. Stem Cells Dev 2009;18: 559-71.
33. Kwon KR, Ahn JY, KimMS, Jung JY, Lee JH, OhIH. Disruption of bis leads to the deterioration of the vascular niche for hematopoietic stem cells. Stem Cells 2010;28: 268-78.
34. +)CD38(-)) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts. Blood 2000;96: 4160-8.
35. Butler JM, Nolan DJ, Vertes EL, Varnum-Finney B, Kobayashi H, Hooper AT, et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 2010;6: 251-64.
36. Chung YS, Kim HJ, Kim TM, Hong SH, Kwon KR, An S, et al. Undifferentiated hematopoietic cells are characterized by a genome-wide undermethylation dip around the transcription start site and a hierarchical epigenetic plasticity. Blood 2009;114: 4968-78.
37. Hong SH, Yang SJ, Kim TM, Shim JS, Lee HS, Lee GY, et al. Molecular integration of HoxB4 and STAT3 for self-renewal of hematopoietic stem cells: A model of molecular convergence for stemness. Stem Cells 2014; 32: 1313-22.
38. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al. A perivascular origin formesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3: 301-13.
39. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential ofmesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 2010;28: 788-98.
40. Nakamura Y, Arai F, Iwasaki H, Hosokawa K, Kobayashi I, Gomei Y, et al. Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood 2010;116: 1422-32.
41. Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, Tomizawa M, et al. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma (null) humanized mice. Proc Natl Acad Sci U S A 2010;107: 13022-7.
42. Liu M, Miller CL, Eaves CJ. Human long-term culture initiating cell assay. Methods Mol Biol 2013;946: 241-56.
43. Heuser M, Argiropoulos B, Kuchenbauer F, Yung E, Piper J, Fung S, et al. MN1 overexpression induces acutemyeloid leukemia inmice and predicts ATRA resistance in patients with AML. Blood 2007;110: 1639-47.
44. Hanoun M, Zhang D, Mizoguchi T, Pinho S, Pierce H, Kunisaki Y, et al. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell 2014;15: 365-75.
45. Arranz L, Sanchez-Aguilera A, Martin-Perez D, Isern J, Langa X, Tzankov A, et al. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms. Nature 2014;512: 78-81.
46. KrevvataM, Silva BC, Manavalan JS, Galan-DiezM, Kode A, Matthews BG, et al. Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts. Blood 2014;124: 2834-46.
47. Jung Y, Song J, Shiozawa Y, Wang J, Wang Z, Williams B, et al. Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche. Stem cells 2008;26: 2042-51.
48. Conneally E, Cashman J, Petzer A, Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabeticscid/scid mice. Proc Natl Acad Sci U S A 1997;94: 9836-41.
49. Cheung AM, Nguyen LV, Carles A, Beer P, Miller PH, Knapp DJ, et al. Analysis of the clonal growth and differentiation dynamics of primitive barcoded human cord blood cells in NSG mice. Blood 2013;122: 3129-37.